First Page | Document Content | |
---|---|---|
Date: 2016-03-03 11:54:31Gilead Sciences Chemistry Fixed dose combination Pharmacology Organic chemistry Bristol-Myers Squibb Non-nucleoside reverse transcriptase inhibitors Organofluorides Tenofovir disoproxil Efavirenz/emtricitabine/tenofovir Tenofovir/emtricitabine Fixed-dose combination | BMS_Gilead_Logo_FINAL.epsAdd to Reading ListSource URL: packageinserts.bms.comDownload Document from Source WebsiteFile Size: 579,03 KBShare Document on Facebook |
A Day in Life at BMS Welcome to A Day in Life at BMS where you will meet leaders from our R&D organization and learn more about research and development at Bristol-Myers Squibb, as well as network with our scientists. ToDocID: 1vrK6 - View Document | |
NoIN THE Supreme Court of the United States BRISTOL-MYERS SQUIBB COMPANY, PETITIONER,DocID: 1tuCc - View Document | |
Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty)DocID: 1tut4 - View Document | |
September 2003 USA Bristol-Myers Squibb Medical ImagingDocID: 1sKnx - View Document | |
May 2003 Bristol-Myers Squibb Medical Imaging 331 Treble Cove Road N. Billerica, Massachusetts 01862DocID: 1sC8T - View Document |